Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Leukemia. 2019 Aug 19;34(1):210–223. doi: 10.1038/s41375-019-0540-7

Figure 1. Morphology of heteroclitic BCMA72-80 peptide-encapsulated nanoparticles (PLGA, liposome) and quantification of BCMA72-80 peptide encapsulation.

Figure 1.

Figure 1.

Figure 1.

A: Scanning electron microscope (SEM) image of gold/palladium sputter-coated BCMA peptide encapsulated PLGA-nanoparticles. Summary of nanoparticle size, PDI and Zeta potential (mV) from three independent experiments (N=3). B: Transmission electron microscope (TEM) image of BCMA peptide encapsulated liposome-nanoparticles after applying uranyl acetate as a negative stain. Summary of nanoparticle size and PDI from three independent experiments (N=3). C: Quantification of BCMA peptide-FITC loading and encapsulation efficiency based on fluorescence intensity measured at Ex/Em at 390 nm/475 nm. Summary of the average of encapsulation efficiency from three independent experiments (N=3).